Melodiol Global Health Ltd
ASX:ME1

Watchlist Manager
Melodiol Global Health Ltd Logo
Melodiol Global Health Ltd
ASX:ME1
Watchlist
Price: 0.001 AUD Market Closed
Market Cap: 1.1m AUD

Intrinsic Value

ME1's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ME1 stock under the Base Case scenario is 0.055 AUD. Compared to the current market price of 0.001 AUD, Melodiol Global Health Ltd is Undervalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ME1 Intrinsic Value
0.055 AUD
Undervaluation 98%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare ME1 to

Fundamental Analysis

Melodiol Global Health Ltd
ASX:ME1
AU
Pharmaceuticals
Market Cap
1.1m AUD
IPO
Oct 20, 2016
AU
Pharmaceuticals
Market Cap
1.1m AUD
IPO
Oct 20, 2016
Price
AU$false
EPS
AU$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ME1?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Melodiol Global Health Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Melodiol Global Health Ltd

Current Assets 5.5m
Cash & Short-Term Investments 692k
Receivables 3m
Other Current Assets 1.9m
Non-Current Assets 13.5m
PP&E 9.7m
Intangibles 3.6m
Other Non-Current Assets 274k
Efficiency

Free Cash Flow Analysis
Melodiol Global Health Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Melodiol Global Health Ltd

Revenue
19.6m AUD
Cost of Revenue
-16.6m AUD
Gross Profit
3m AUD
Operating Expenses
-19.3m AUD
Operating Income
-16.3m AUD
Other Expenses
-36.2m AUD
Net Income
-52.4m AUD
Fundamental Scores

ME1 Profitability Score
Profitability Due Diligence

Melodiol Global Health Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
ROIC is Increasing
Positive Gross Profit
27/100
Profitability
Score

Melodiol Global Health Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ME1 Solvency Score
Solvency Due Diligence

Melodiol Global Health Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
65/100
Solvency
Score

Melodiol Global Health Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ME1 Price Targets Summary
Melodiol Global Health Ltd

There are no price targets for ME1.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Melodiol Global Health Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ME1 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ME1 Insider Trading
Buy and sell transactions by insiders